Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Caraux, Anouk; Vincent, Laure; Bouhya, Salahedine; Quittet, Philippe; Moreaux, Jérôme; Requirand, Guilhem; Veyrune, Jean-Luc; Olivier, Gaëlle; Cartron, Guillaume; Rossi, Jean-François; Klein, Bernard.
Oncotarget; 3(11): 1335-47, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23154454